Bruker Online Neuroscience Summit 2025: Innovations in Brain Research

I bet your incompetent hospital won't have their stroke medical 'professionals' attend this!

Like maybe this one:
Neurovascular Research
"Manipulating Blood Flow with Optogenetics" Philip O’Herron 8:10 am - 9:00 am

And this:

"Molecular Genetics Toolset for Brain Microcirculation Imaging (and Beyond)" Hajime Hirase 9:50 am - 10:20 am

 Bruker Online Neuroscience Summit 2025: Innovations in Brain Research

Overview

Join us for the Bruker Neuroscience Online Summit 2025, a two-day virtual event on April 22 and 23, 2025, from 8 AM to 10:30 AM (PDT) each day. This summit will showcase groundbreaking research from leading scientists utilizing advanced imaging technologies, including Bruker two-photon microscopes, miniscopes from Inscopix, and Bruker Spatial Biology equipment, to explore neuronal activity in the brain. Over the course of the summit, attendees will have the opportunity to hear from leading scientists presenting their latest findings across six key areas of neuroscience: 

• Optogenetics 

• Psychiatric Disorders 

• Neurovascular Research 

• Behavioral Studies 

• Leading-edge Technology from Bruker Scientists 

 Each topic will feature a series of three experts, providing in-depth insights and fostering discussions on the latest advancements and applications in neuroscience research. Don't miss this chance to connect with the scientific community and stay at the forefront of neuroscience innovation. Register now to secure your spot and be part of this exciting event! Full list of talks, presenters, and abstracts: https://www.bruker.com/en/news-and-events/events/bruker-online-neuroscience-summit-2025.html

Stroke Recovery Strategies June 16 webinar by Anysia Ensslen-Boggs, Ed.D., M.S., CCC-SLP

Looking at the objectives and outline there is nothing on recovery protocols to use, so in my opinion, worthless.

Stroke Recovery Strategies June 16 webinar by Anysia Ensslen-Boggs, Ed.D., M.S., CCC-SLP

 

• Learning Objectives

1. Identify various etiologies of cognitive deficits as they relate to the neuroanatomy of strokes.
2. Define principles of experience-dependent neuroplasticity and its impact on rehabilitation.
3. Select appropriate screenings and assessments to informally and formally evaluate cognitive deficits.
4. Explain how various cognitive impairments impact the patient's ability to meet transdisciplinary treatment objectives.
5. Implement treatment techniques for orientation, short-term memory, safety awareness, and executive functioning forfunctional improvement of ADL's across all therapydisciplines.
6. Compose measurable goals that allow for documentation of patient outcomes.

Outline

1. The Current Landscape of Cognitive Deficits
   1. Stroke as etiology
   2. Neuroanatomy
   3. Orientation and awareness
   4. Attention
   5. Memory
   6. High-level cognitive deficits associated with right CVA
2. Assessment of Cognitive Deficits Following Stroke
   1. SLUMS
   2. MoCA
   3. Other standardized assessments and screening tools
   4. Criterion-referenced assessments
   5. Setting functional treatment objectives
3. Leveraging Neuroplasticity for Stroke Recovery
   1. What is neuroplasticity?
   2. 10 principles of experience-dependent neuroplasticity
   3. Neuroplasticity and evidence-based practice
   4. Application to levels of assistance and cueing hierarchy
4. Intervention Strategies to Improve ADLs
   1. Treatment techniques for improving functional cognition
   2. Utilizing neuroplasticity to achieve functional treatment objectives
   3. Improving completion of ADLs by improving cognition
   4. Executive functioning and application to patient safety and independence
   5. Examples of cognitive interventions
5. Effectively Communicating Across a Multidisciplinary Team
   1. Targeting cognitive goals in PT and OT
   2. Co-treating/interdisciplinary treatment plans
   3. Family/caregiver/staff education
   4. Discharge plans: Is this patient safe at home?
6. Accurate Documentation Tips and Tricks
   1. Goal-writing
   2. Patient outcomes
   3. Justifying medical necessity
   4. ICD-10 and Medicare guidelines
7. Case Studies
   1. Review of case studies in small interdisciplinary groups
   2. Application of knowledge
   3. Discussion
   4. Case Study

Life after stroke webinar series 2021: Shining a spotlight on life after stroke

Another proof that the tyranny of low expectations infects all of stroke. If you got survivors 100% recovered you wouldn't have to do this kind of stuff at all. Please work yourself out of a job like the Michael J. Fox Foundation is trying to do.  Since your hospitals have to do this it means they are a complete failure in getting survivors recovered.

Or is this the problem?

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life after stroke webinar series 2021: Shining a spotlight on life after stroke

Register now for the webinar series https://bit.ly/3cXlJFR

There are nine million people living with stroke in Europe.

The pandemic has worsened the stroke burden and the number of stroke survivors is predicted to increase due to an ageing population. Life after stroke care and support is even more important than ever and must be a priority for health and social care across Europe.

The life after stroke series of free interactive events is an opportunity to build the life after stroke healthcare, research and patient community, stimulate debate and ultimately improve life after stroke care and build interest for our 1^st European Life After Stroke Forum on 11 March 2022.

 

Life after stroke: priorities, challenges and ways forward?

In our opening session on Friday 12 March 09.00-10.30 GMT, our aim is to highlight key issues affecting stroke survivors in the longer-term after stroke and share examples of good practice and what ‘good’ long-term support looks like in a post-pandemic context.

We will hear updates from Bo Norrving (Sweden)(former president of the WSO, I could see nothing that he accomplished for survivors.), Juliet Bouverie (UK), Liam Healy (Ireland) and Caterina Pistarini (Italy) on people’s experiences of the impact of stroke before and during the pandemic, and how healthcare and support services have adapted to meet the challenges of post-pandemic stroke care.

We will learn about new and creative ways of offering support such as using telemedicine and telerehabilitation and remote methods of looking after stroke survivors.

This interactive session is for anyone with an interest in stroke support and care including clinicians, stroke survivors and carers as well as stroke support organisations across the globe.

Participation and registration is free.

Register now for the webinar series https://bit.ly/3cXlJFR

#LifeAfterStroke

We hope to see you then!

SAFE team

 

But that’s the way we’ve always done it! Changing organizational culture in medical R&D

This is so true of our fossilized and decrepit stroke associations. But the boards of directors seem not to notice or care that they are fucking failures.
http://www.fastercures.org/events/webinars/show/but-thats-the-way-weve-always-done-it-changing-organizational-culture-in-medical-r-and-d

Many of the behaviors slowing faster progress in the discovery and development of new medical products are things that organizations everywhere have been confronting for decades, if not centuries – lack of effective communication and collaboration, silo-ization of information and expertise, incentives not aligned with the collective behaviors we want to see. What can the biomedical R&D ecosystem learn from the vast literature and learnings from outside the space about how to change organizational culture and behavior to build a more effective, efficient enterprise?
Speakers include:

• Riley Ennis, Co-Founder and Chief Operating Officer, Freenome
• Richard Hamermesh, Senior Fellow, Harvard Business School
• Lyric Jorgenson, Deputy Director, Office of Science Policy, National Institutes of Health
• Margaret Anderson, Executive Director, FasterCures, a center of the Milken Institute (moderator)

Summary

Culture change is more likely to occur if you treat it as a response to opportunity, not a response to failure. That seemingly simple but wise observation from Lyric Jorgenson, deputy director of the Office of Science Policy at the National Institutes of Health, captured the tone of a fascinating Webinar discussion titled “But That’s the Way We’ve Always Done It! Changing Organizational Culture in Medical R&D.” Jorgenson, Harvard Business School Senior Fellow Richard Hamermesh, and Freenome Co-founder and Entrepreneur Riley Ennis brought very different perspectives to the topic. But they agreed that opportunities created by advances in science and technology require change to “the way we’ve always done things” to maximize their potential. This change in scientific research could accelerate progress where decades of talking about the problems have failed.
Since our earliest days, FasterCures has been focused on the ways the culture of medical research can slow progress. We heard from the patient-driven venture philanthropies that became The Research Acceleration and Innovation Network their frustration that “culture eats strategy for breakfast” – or in this case, scientific progress. They saw lack of communication and collaboration and misaligned incentives as being significant drags on progress, as much as the state of the science, and they set out to do what they could as funders to address those cultural issues. “Change starts with small, visible successes that are built on quickly,” Hamermesh noted, and cited venture philanthropies like the Cystic Fibrosis Foundation and the Multiple Myeloma Research Foundation as organizations that have done exactly that.
Start small and build on success. Identify opportunities that can drive culture change. What else do we know about how change happens? Jorgenson cited her experience as deputy director of Vice President Joe Biden’s Cancer Moonshot saying, “A push from the masses plus a pull from a champion,” someone who will challenge people’s assertions about the way we’ve always done things and hold partners accountable, is key. She also acknowledged that a crisis can spark culture change, as happened with HIV/AIDS, but ideally is managed by strong leadership that can allay people’s concerns about the consequences.
Ennis cited how data drive change – and in an era in which we are inundated with data, that is certainly an opportunity. Ennis emphasized the need to have a certain amount of humility, understand why things are done the way they are, and respect the needs of your partners. But “the system needs to be more open-minded and data-driven,” said Ennis. He encouraged the biomedical R&D ecosystem to learn lessons from the technology sector about using real-time feedback loops to improve the quality of data and reduce iteration cycles. He also mentioned that “failure” can catalyze growth – for individuals, for organizations, and for science. This was echoed by Jorgenson when she appealed for a rethinking of how clinical trials can be shifted to a more adaptive, flexible system where we can fail fast and move on. Ennis also raised the utility of data technologies, like artificial intelligence and machine learning, in changing the rules of the game.
What elements of the biomedical R&D culture need to have the levers of change applied to accelerate progress? Several themes emerged across the speakers’ comments:

• More sharing of data. The opportunity of precision medicine is upon us, said Hamermesh. But without large, broadly available datasets to drive insights, it will fail to become reality. “Let’s not have data hoarding,” he pleaded. Ennis advocated for centralizing data for queries. We may be swimming in data, but if we can’t aggregate, access, and analyze them, they don’t matter.
• Greater diversity of experiences and perspectives. Hamermesh invoked the power of crowdsourcing to bring fresh expertise and ideas to solving biomedical research questions, asserting that “change will come from outside the system.” Jorgenson talked about the need to empower non-traditional partnerships and multi-disciplinary teams in order to crack the complexities of biology today. Additionally, we should give researchers training opportunities that expose them to other ways of thinking.
• A person-centered approach. All speakers talked about the ways in which a focus on the individual patient and person will disrupt the way we do things. Hamermesh believes that when people understand their own health data, and share them with open datasets for research, a revolution will occur – a view that Jorgenson shared. Precision medicine is, of course, a person-centered endeavor. Ennis talked about the importance of removing complexity by focusing on the things people care about – making their data actionable and giving them real-time feedback that informs their choices impacting their health. Patient-reported outcomes are a critical feedback loop to improve data quality, in Ennis’s view. 

What incentives are needed to foster the changes in behavior we say we want to see?

• Jorgenson hit on the need for institutions to reward researchers for data quality and methodological rigor with citations and recognition that build their careers. Data that are not of high quality, not shared, or not reproducible are not of high value to the enterprise. 
• Individuals need to be incentivized and enabled to acquire, understand, and share their health data. Hamermesh cited lessons to be learned from direct-to-consumer businesses like Rent the Runway and Uber about engaging with and adding value for consumers. 

When asked by FasterCures’ Executive Director Margaret Anderson how we can accelerate culture change in medical R&D, all three speakers came back to the centrality of individual people and patients driving disruption in the system, as they have in so many other sectors. Hamermesh summed it up by saying, “Start by going directly to the patients. Free up their data, and they will change the system, ask better questions, and create a sense of urgency.” And Ennis put it simply, “Treat users as people, not patients.”

Live webinar - Virtual Rehabilitation – How Feedback and Motivation Influence Neurological Therapy Outcome

You will notice that they are proposing trying to fix the effects of the stroke rather than preventing a lot of the damage by stopping the 5 causes of the  neuronal cascade of death in the first week.  Or delivering  this:
My 31 ideas on hyperacute therapy I'm going to insist my doctor give me during the first week. 
Or these needing a lot more research:
These 177 hyperacute therapies that need more research.
I've got 6 posts on Dr. John Krakauer already, he has some great ideas, virtual dolphins, calls stroke rehab medieval.
 

Live webinar - Virtual Rehabilitation – How Feedback and Motivation Influence Neurological Therapy Outcome

Live-Webinar on February 8, 2017,
09:00 a.m. Baltimore (US) / 3:00 p.m. Berlin (GER) / 10:00 p.m. Hong Kong (CN)

Guest speakers:

Prof. Dr. John Krakauer

Professor of Neurology and Neuroscience, Johns Hopkins University School of Medicine, US

Maarten Prins
VR Rehabilitation Therapist and Researcher, Military Rehabilitation Center, Doorn, NL

Key factors for successful recovery of neurological and neuromuscular patients are, among others, motivation and engagement, feedback for both patient and therapist, and having to do movement tasks in a varied environment. Virtual reality can provide innovative therapeutic solutions to enhance these factors in the rehabilitation field. What’s more, virtual reality is already well integrated and established in many clinics as a rehabilitation tool all over the world. In this exclusive webinar, two experts will share their experiences on using virtual reality in a rehabilitation setting.  

 

Webinar: 25 Must-Know Facts to Harness Neuroplasticity & Technology For Better Brain Health

I most certainly will not be attending, it is just going to be generalities. Notice that there are no references to protocols or results.

Webinar: 25 Must-Know Facts to Harness Neuroplasticity & Technology For Better Brain Health

The main objective is for all participants–no previous knowledge required–to understand 25 fundamental facts to understand and apply the latest brain science to improve brain health. Our distinguished Faculty will clarify hot topics around IQ, creativity, resilience, cognitive enhancement, Alzheimer’s prevention, left/ right brain hemispheres, brain supplements, learning styles, brain training, meditation, neurofeedback, neurogenesis, neuroplasticity, and more.
Available online from anywhere with an Internet connection, this webinar will provide participants with the must-know foundation to understand both the value and the limitations of emerging science and technologies, empowering you to make sound decisions and enhance brain health and function.
When: Thursday, April 21st, 2016. 10:30am-noon US Pacific Time/ 1.30-3pm US Eastern Time.
With those 25 Must-Know Facts we will zoom into the most significant (and often overlooked) areas in the brain fitness jigsaw puzzle you can see above. We won't discuss generalities, we will discuss specifics about:

• How the brain works, and what neuroplasticity is
• What new scientific findings mean (and what they don't mean)
• Key guidelines for aerobic exercise, nutrition, mental stimulation, stress management, socialization
• The do's and don'ts in leveraging technology for meditation, reframing, bio/ neurofeedback, cognitive training
• How to self-monitor, find individual priorities, prioritize options

We hope you will be able to register and join us! (use this 20%-off discount when you register: SB20) 

Studies to Slow or Stop Parkinson's Disease

At least the Michael J. Fox foundation has  research information on their disease they are willing to publicly disseminate. Our stroke associations have NOTHING. You are completely on your own. Better start saving money to hire your own research team.

	Third Thursdays Webinar Studies to Slow or Stop Parkinson's Disease
	Thursday, October 15, 12 to 1 p.m. ET
	Register Now >
	Our next webinar will cover therapies with the potential to stop Parkinson's disease that have progressed to clinical testing in humans. Listen to a preview podcast with MJFF CEO Todd Sherer, PhD. Then register to join our October 15 webinar and learn more.  Q & A with participants will follow the discussion.   Watch previous Third Thursdays Webinars at www.michaeljfox.org/webinars.